Nuclein

About:

Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.

Website: https://nuclein.com

Top Investors: Trinity Private Equity Group

Description:

Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour, without the need to mail in a sample.

Total Funding Amount:

$28.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2017-01-01

Founders:

Alan Blake, Richard Crockett

Number of Employees:

11-50

Last Funding Date:

2024-08-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai